These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of long-term hormone replacement therapy: results from a cohort study. Signorelli SS; Sciacchitano S; Anzaldi M; Fiore V; Catanzaro S; Simili M; Neri S J Endocrinol Invest; 2011 Mar; 34(3):180-4. PubMed ID: 20414045 [TBL] [Abstract][Full Text] [Related]
5. Effects of estrogen and estrogen-progesteron on serum nitric oxide metabolite concentrations in post-menopausal women. Bednarek-Tupikowska G; Tworowska-Bardzinska U; Tupikowski K J Endocrinol Invest; 2008 Oct; 31(10):877-81. PubMed ID: 19092292 [TBL] [Abstract][Full Text] [Related]
6. Activation of estrogen receptor-alpha by the anion nitrite. Veselik DJ; Divekar S; Dakshanamurthy S; Storchan GB; Turner JM; Graham KL; Huang L; Stoica A; Martin MB Cancer Res; 2008 May; 68(10):3950-8. PubMed ID: 18483281 [TBL] [Abstract][Full Text] [Related]
7. Are endocrine disrupting compounds a health risk in drinking water? Falconer IR Int J Environ Res Public Health; 2006 Jun; 3(2):180-4. PubMed ID: 16823090 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of estrogen replacement on plasma nitric oxide levels: results from the estrogen in the prevention of atherosclerosis trial (EPAT). Hwang J; Mack WJ; Xiang M; Sevanian A; Lobo RA; Hodis HN Atherosclerosis; 2005 Aug; 181(2):375-80. PubMed ID: 16039293 [TBL] [Abstract][Full Text] [Related]
9. Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis. Vigen C; Hodis HN; Chandler WL; Lobo RA; Mack WJ J Thromb Haemost; 2007 Jun; 5(6):1201-8. PubMed ID: 17389005 [TBL] [Abstract][Full Text] [Related]
10. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Mack WJ; Hameed AB; Xiang M; Roy S; Slater CC; Stanczyk FZ; Lobo RA; Liu CR; Liu CH; Hodis HN Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391 [TBL] [Abstract][Full Text] [Related]
11. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP; Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394 [TBL] [Abstract][Full Text] [Related]
12. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP; N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912 [TBL] [Abstract][Full Text] [Related]
13. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women. Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528 [TBL] [Abstract][Full Text] [Related]